Author: bkellaway

The Addiction Medicine Foundation Accredits Four More Fellowship Programs, Bringing Total Accredited Programs to 40

The Addiction Medicine Foundation today announced the accreditation of four additional fellowship programs to train addiction medicine physicians. The Foundation has supported the establishment of 40 addiction medicine fellowship training programs to date, based at major medical schools and hospitals across North America.

Study Finds Addiction Associated with Poor Awareness of Others

Original post: Newswise - Drug and Drug Abuse Study Finds Addiction Associated with Poor Awareness of Others

Developmental psychologist finds adolescents with severe alcohol and other drug (AOD) problems have a low regard for others, as indicated by higher rates of driving under the influence and having unprotected sex with a history of sexually transmitted disease.

Opioid Relapse Rates Fall with Long-Term Use of Medication for Adults Involved in Criminal Justice System

A clinical trial from NYU Langone Medical Center and others finds use of long-term, extended-release naltrexone leads to decreases in opioid addiction relapse. Learn more.

Naltrexone Is Alternative Treatment for Opioid Addiction, Penn-Led Study Finds

Original post: Newswise - Drug and Drug Abuse Naltrexone Is Alternative Treatment for Opioid Addiction, Penn-Led Study Finds

The once-a-month drug naltrexone was more effective at preventing drug relapse in ex-prisoners addicted to heroin and other opioids compared to the usual treatment modalities, including counseling and community treatment programs, according to results from a multisite, randomized trial led by researchers at the Center for Studies of Addiction at the Perelman School of Medicine at the University of Pennsylvania and published online today in the New England Journal of Medicine.